Hira B. Pant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hira B. Pant has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- A. Y. Nirupama
Indian Institute of Public Health, Hyderabad, India
1 shared publication - Abhilash Patra
Indian Institute of Public Health, Hyderabad, India
1 shared publication - Gudlavalleti Venkata Satyanarayana Murthy
Indian Institute of Public Health, Hyderabad, India
1 shared publication - Rebecca DeSouza
Nag Foundation, Pune, India
1 shared publication - Shona Nag
Medical Oncology Department, Sahyadri Superspeciality Hospital, Hadapsar, Pune, India
1 shared publication - Shriniwas Subhash Kulkarni
Oncology Department, Sahyadri Group of Hospital, Pune, India
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 10 (1)
Health-related quality of life (HRQoL) of women with breast cancer undergoing treatment in a tertiary care centre in India
Introduction: Breast cancer in India accounts for 178361 of all cancers (Globocan 2020 report). Treatment causes financial, social, and psychological stress, impacting patients’ quality of life (QoL). Multiple studies have reported QoL among survivors, however few studies focused on patients undergoing treatment in India. Hence, the present study aimed to measure the QoL and its influencing factors associated with breast cancer undergoing various treatments in the oncology department of a tertiary care hospital in India. Methods: A hospital-based cross-sectional study (Nov 2022 - Jan 2023) used a semi-structured questionnaire on participants’ sociodemographic and clinical characteristics. The validated Marathi and English EORTC QLQ-C30 and BR23 assessed QoL. Participants were selected using convenience sampling. Results: A total of 285 patients agreed to participate with a mean age of 54.2 ± 12.2 years and the mean score of Global Health Status (GHS)/QoL was 54.4 ± 19.6. Patients who received radiation had more pain ( p < 0.001), insomnia ( p < 0.001), and diarrhoea ( p = 0.005), whereas, those who received chemotherapy had higher scores in constipation ( p < 0.001) and loss of appetite ( p = 0.001). Co-morbidities were significantly associated with breast cancer-specific symptoms scales – upset by hair loss ( p = 0.025), arm symptoms ( p = 0.026), and breast symptoms ( p = 0.013). Conclusion: Education, occupation, hours of sleep, financial issues, and type of surgery were linked to the patient’s QoL. Therefore, these patients require additional attention and support services, including effective pain management and interventions to enhance sleep quality, to further enhance their QoL. Longitudinal studies incorporating detailed clinical and psychosocial variables are needed to understand the determinants of QoL.
- 21 April 2026
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 10 (1)
Open AccessHealth-related quality of life (HRQoL) of women with breast cancer undergoing treatment in a tertiary care centre in India
Introduction: Breast cancer in India accounts for 178361 of all cancers (Globocan 2020 report). Treatment causes financial, social, and psychological stress, impacting patients’ quality of life (QoL). Multiple studies have reported QoL among survivors, however few studies focused on patients undergoing treatment in India. Hence, the present study aimed to measure the QoL and its influencing factors associated with breast cancer undergoing various treatments in the oncology department of a tertiary care hospital in India. Methods: A hospital-based cross-sectional study (Nov 2022 - Jan 2023) used a semi-structured questionnaire on participants’ sociodemographic and clinical characteristics. The validated Marathi and English EORTC QLQ-C30 and BR23 assessed QoL. Participants were selected using convenience sampling. Results: A total of 285 patients agreed to participate with a mean age of 54.2 ± 12.2 years and the mean score of Global Health Status (GHS)/QoL was 54.4 ± 19.6. Patients who received radiation had more pain ( p < 0.001), insomnia ( p < 0.001), and diarrhoea ( p = 0.005), whereas, those who received chemotherapy had higher scores in constipation ( p < 0.001) and loss of appetite ( p = 0.001). Co-morbidities were significantly associated with breast cancer-specific symptoms scales – upset by hair loss ( p = 0.025), arm symptoms ( p = 0.026), and breast symptoms ( p = 0.013). Conclusion: Education, occupation, hours of sleep, financial issues, and type of surgery were linked to the patient’s QoL. Therefore, these patients require additional attention and support services, including effective pain management and interventions to enhance sleep quality, to further enhance their QoL. Longitudinal studies incorporating detailed clinical and psychosocial variables are needed to understand the determinants of QoL.